Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4724 total record number 96 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 5 out of 34
334 citations found

Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity

Kim, E;Attia, Z;Woodfint, RM;Zeng, C;Kim, SH;Steiner, HE;Shukla, RK;Liyanage, NPM;Ghimire, S;Li, J;Renukaradhya, GJ;Satoskar, AR;Amer, AO;Liu, SL;Cormet-Boyaka, E;Boyaka, PN;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses

Budden, CF;Gearing, LJ;Kaiser, R;Standke, L;Hertzog, PJ;Latz, E;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway

Evavold, CL;Hafner-Bratkovi?, I;Devant, P;D'Andrea, JM;Ngwa, EM;Borši?, E;Doench, JG;LaFleur, MW;Sharpe, AH;Thiagarajah, JR;Kagan, JC;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax

Martchenko Shilman, M;Bartolo, G;Alameh, S;Peterson, JW;Lawrence, WS;Peel, JE;Sivasubramani, SK;Beasley, DWC;Cote, CK;Demons, ST;Halasahoris, SA;Miller, LL;Klimko, CP;Shoe, JL;Fetterer, DP;McComb, R;Ho, CC;Bradley, KA;Hartmann, S;Cheng, LW;Chugunova, M;Kao, CY;Tran, JK;Derbedrossian, A;Zilbermintz, L;Amali-Adekwu, E;Levitin, A;West, J;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Detection of PA and Anti-PA IgG in Serum

    PA was measured in serum using PA-ECL screening assay kit MesoScale Discovery (L15CA-1), which utilizes the anti-PA antibody. To quantitate the levels of PA in each serum sample, a standard curve (0–100 ng/mL) was analyzed in parallel on each assay day by using recombinant PA (List Biological Laboratories, Inc., 171E). Test samples were assayed in duplicate.

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Label-free and Rapid Detection of Anthrax Protective Antigen by Surface-enhanced Raman Scattering on Au Nanorods

Li, B;Wang, T;Bai, W;Su, Q;Wu, X;Dong, P;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation

Vijay, R;Guthmiller, JJ;Sturtz, AJ;Crooks, S;Johnson, JT;Li, L;Lan, LY;Pope, RL;Chen, Y;Rogers, KJ;Dutta, N;Toombs, JE;Wilson, ME;Wilson, PC;Maury, W;Brekken, RA;Butler, NS;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals

Smith, K;Garman, L;Norris, K;Muther, J;Duke, A;Engler, RJM;Nelson, MR;Collins, LC;Spooner, C;Guthridge, C;James, JA;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Hydrophobic Gating and 1/f Noise of the Anthrax Toxin Channel

Yamini, G;Kanchi, S;Kalu, N;Momben Abolfath, S;Leppla, SH;Ayappa, KG;Maiti, PK;Nestorovich, EM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis

Phulphagar, K;Kühn, LI;Ebner, S;Frauenstein, A;Swietlik, JJ;Rieckmann, J;Meissner, F;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • STAR★Methods
    KEY RESOURCES TABLE
    REAGENT or RESOURCE SOURCE IDENTIFIER

    Chemicals, peptides, and recombinant proteins

    Lethal factor List Biologicals Cat#172B

    Protective antigen List Biologicals Cat#171E

    Activation of BMDMs and human macrophages

    All cells were grown, maintained and activated at 37°C and 5% CO2 in a water-jacketed incubator. 1 × 106 WT or Casp1/11 DKO murine macrophages were plated per 12-well in DMEM, 10% (v/v) FCS (DMEM complete medium) one day prior to stimulation. All BMDMs were primed with 200 ng/mL LPS from Salmonella Typhimurium for 2 h or left untreated and subsequently washed three times with serum- and phenol red-free DMEM supplemented with 2 mM L-glutamine (DMEM minimal medium). For the time course experiment (Dataset 1), cells were preincubated with 0 or 100 μM glyburide (#NBP2-30141, Novus Biologicals) for 15-30min before 2 mM ATP (#7699, Sigma) or 10 μM nigericin (N1495, Invitrogen) were added for 15, 30, 45, and 60 min. Lethal factor and protective antigen were added at 1ug/ml. …

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis
    Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis